The Measurement Error Elephant in the Room: Challenges and Solutions to Measurement Error in Epidemiology is a research paper published in Epidemiologic Reviews (2021). On theSindex it has a DataRank of 1.2. It has been cited 54 times, with 41 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.601
From this paper's citation signal
Citation Network Contribution
0.595
From 21 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 41 citers.
National Institutes of Health
Grant: U01-AA020793
National Institutes of Health
Grant: R01-CA250851
National Institutes of Health
Grant: P30-AI094189
National Institutes of Health
Grant: R24-AI067039
National Institutes of Health
Grant: U24-OD023382
National Institutes of Health
Grant: U01-HL146193
National Institutes of Health
Grant: 1R01AG052412
National Institutes of Health
Grant: U01-DK-66143
National Institutes of Health
Grant: U01-DK-66174
National Institutes of Health
Grant: U01DK-082194
National Institutes of Health
Grant: U01-DK-66116
NIAAA NIH HHS
Grant: U01 AA020793
NIAID NIH HHS
Grant: R01 AI170240
NIDDK NIH HHS
Grant: U01 DK082194
NHLBI NIH HHS
Grant: U01 HL146193
NIDDK NIH HHS
Grant: U01 DK066143
NIDDK NIH HHS
Grant: U01 DK066174
NIA NIH HHS
Grant: R01 AG052412
NIH HHS
Grant: U24 OD023382
NIAID NIH HHS
Grant: R24 AI067039
NIDDK NIH HHS
Grant: U01 DK066116
NIAID NIH HHS
Grant: P30 AI094189
NCI NIH HHS
Grant: R01 CA250851
National Institutes of Health
Grant: 5U01HL146193-07
Data Analysis and Coordination Center for the MACS-WIHS Combined Cohort Study
National Institutes of Health
Grant: 5U01DK066143-10
Chronic Kidney Disease in Children (CKiD)
National Institutes of Health
Grant: 3P30AI094189-13S3
The Johns Hopkins Center for AIDS Research (JHU CFAR)
National Institutes of Health
Grant: 5U24OD023382-07
ECHODAC (Environmental Influences on Child Health Outcomes Data Analysis Center)
National Institutes of Health
Grant: 5R01CA250851-03
Medicaid data as a complement to cohort studies for investigating cancers among older people with HIV
National Institutes of Health
Grant: 2U01AA020793-06
3/4 Alcohol Research Consortium in HIV - Epidemiological Research Arm (ARCH-ERA)
National Institutes of Health
Grant: 2U01DK066116-11
The Kidney Disease in Children Data Management and Analysis Center (KIDMAC)
National Institutes of Health
Grant: 5U01DK066174-03
Chronic Kidney Disease in Children Study (C-Kid)
FWCI
7.03
Citation Percentile
1.0%
Influential Citations
1
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Silence is golden, but my measures still see—why cheaper-but-noisier outcome measures in large simple trials can be more cost-effective than gold standards
Additional file 1 of Silence is golden, but my measures still see—why cheaper-but-noisier outcome measures in large simple trials can be more cost-effective than gold standards
Additional file 2 of Silence is golden, but my measures still see—why cheaper-but-noisier outcome measures in large simple trials can be more cost-effective than gold standards
Additional file 2 of Silence is golden, but my measures still see—why cheaper-but-noisier outcome measures in large simple trials can be more cost-effective than gold standards
Additional file 3 of Silence is golden, but my measures still see—why cheaper-but-noisier outcome measures in large simple trials can be more cost-effective than gold standards
Additional file 3 of Silence is golden, but my measures still see—why cheaper-but-noisier outcome measures in large simple trials can be more cost-effective than gold standards
Additional file 4 of Silence is golden, but my measures still see—why cheaper-but-noisier outcome measures in large simple trials can be more cost-effective than gold standards
Additional file 4 of Silence is golden, but my measures still see—why cheaper-but-noisier outcome measures in large simple trials can be more cost-effective than gold standards
Additional file 6 of Silence is golden, but my measures still see—why cheaper-but-noisier outcome measures in large simple trials can be more cost-effective than gold standards
Additional file 6 of Silence is golden, but my measures still see—why cheaper-but-noisier outcome measures in large simple trials can be more cost-effective than gold standards
Additional file 7 of Silence is golden, but my measures still see—why cheaper-but-noisier outcome measures in large simple trials can be more cost-effective than gold standards
Additional file 5 of Silence is golden, but my measures still see—why cheaper-but-noisier outcome measures in large simple trials can be more cost-effective than gold standards
Additional file 5 of Silence is golden, but my measures still see—why cheaper-but-noisier outcome measures in large simple trials can be more cost-effective than gold standards
Additional file 7 of Silence is golden, but my measures still see—why cheaper-but-noisier outcome measures in large simple trials can be more cost-effective than gold standards